CVD.TO vs. RYTM

Last updated Jun 9, 2026

CVD.TO (iShares Convertible Bond Index ETF) is High Yield Bonds fund tracking the FTSE Canada Convertible Bond Index, while RYTM (Rhythm Pharmaceuticals, Inc.) is a stock. Over the past 5 years, CVD.TO returned 4.41%/yr vs 39.11%/yr for RYTM. At a 0.03 correlation, their price movements are largely independent.

Performance

CVD.TO vs. RYTM - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in iShares Convertible Bond Index ETF (CVD.TO) and Rhythm Pharmaceuticals, Inc. (RYTM). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

CVD.TO is traded in CAD, while RYTM is traded in USD. To make them comparable, the RYTM values have been converted to CAD using the latest available exchange rates.

Returns By Period

In the year-to-date period, CVD.TO achieves a 3.34% return, which is significantly higher than RYTM's -18.26% return.

CVD.TO

• 1D: -0.28%
• 1M: 0.60%
• YTD: 3.34%
• 6M: 0.88%
• 1Y: 7.85%
• 3Y*: 8.29%
• 5Y*: 4.41%
• 10Y*: 4.51%

RYTM

• 1D: -0.28%
• 1M: -6.86%
• YTD: -18.26%
• 6M: -17.66%
• 1Y: 28.72%
• 3Y*: 72.63%
• 5Y*: 39.11%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CVD.TO vs. RYTM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CVD.TO iShares Convertible Bond Index ETF	3.34%	7.09%	12.68%	3.64%	-4.63%	5.33%	3.67%	10.28%	-2.68%	1.60%
RYTM Rhythm Pharmaceuticals, Inc.	-18.26%	82.48%	32.09%	54.11%	210.27%	-66.45%	26.41%	-18.10%	0.28%	26.07%

Correlation

The correlation between CVD.TO and RYTM is -0.12, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.12
Correlation (3Y) Calculated over the trailing 3-year period	-0.01
Correlation (5Y) Calculated over the trailing 5-year period	0.01
Correlation (All Time) Calculated using the full available price history since Oct 5, 2017	0.03

The correlation between CVD.TO and RYTM shifts across timeframes, from -0.12 (1 year) to 0.03 (all time), reflecting how their relationship changes across market environments.

Return for Risk

CVD.TO vs. RYTM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CVD.TO

CVD.TO Risk / Return Rank: 37
CVD.TO Sharpe Ratio Rank: 33
CVD.TO Sortino Ratio Rank: 31
CVD.TO Omega Ratio Rank: 37
CVD.TO Calmar Ratio Rank: 44
CVD.TO Martin Ratio Rank: 39

RYTM

RYTM Risk / Return Rank: 60
RYTM Sharpe Ratio Rank: 58
RYTM Sortino Ratio Rank: 62
RYTM Omega Ratio Rank: 59
RYTM Calmar Ratio Rank: 59
RYTM Martin Ratio Rank: 59

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CVD.TO vs. RYTM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Convertible Bond Index ETF (CVD.TO) and Rhythm Pharmaceuticals, Inc. (RYTM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CVD.TO	RYTM	Difference
Sharpe ratio: Return per unit of total volatility	1.08	0.50	+0.58
Sortino ratio: Return per unit of downside risk	1.52	1.35	+0.17
Omega ratio: Gain probability vs. loss probability	1.23	1.15	+0.07
Calmar ratio: Return relative to maximum drawdown	1.99	0.82	+1.17
Martin ratio: Return relative to average drawdown	5.73	1.89	+3.84
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CVD.TO vs. RYTM - Sharpe Ratio Comparison

The current CVD.TO Sharpe Ratio is 1.08, which is higher than the RYTM Sharpe Ratio of 0.50. The chart below compares the historical Sharpe Ratios of CVD.TO and RYTM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CVD.TO	RYTM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.08	0.50	+0.58
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.47	0.51	-0.04
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.48	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.46	0.25	+0.21

Drawdowns

CVD.TO vs. RYTM - Drawdown Comparison

The maximum CVD.TO drawdown since its inception was -23.51%, smaller than the maximum RYTM drawdown of -91.95%. Use the drawdown chart below to compare losses from any high point for CVD.TO and RYTM.

Drawdown Indicators

	CVD.TO	RYTM	Difference
Max Drawdown Largest peak-to-trough decline	-23.51%	-91.95%	+68.44%
Max Drawdown (1Y) Largest decline over 1 year	-3.95%	-35.25%	+31.30%
Max Drawdown (3Y) Largest decline over 3 years	-11.47%	-35.25%	+23.78%
Max Drawdown (5Y) Largest decline over 5 years	-14.62%	-84.60%	+69.98%
Max Drawdown (10Y) Largest decline over 10 years	-23.51%	—	—
Current Drawdown Current decline from peak	-1.89%	-26.13%	+24.24%
Average Drawdown Average peak-to-trough decline	-2.39%	-31.15%	+28.76%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.37%	15.26%	-13.89%

Volatility

CVD.TO vs. RYTM - Volatility Comparison

The current volatility for iShares Convertible Bond Index ETF (CVD.TO) is 1.02%, while Rhythm Pharmaceuticals, Inc. (RYTM) has a volatility of 14.54%. This indicates that CVD.TO experiences smaller price fluctuations and is considered to be less risky than RYTM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CVD.TO	RYTM	Difference
Volatility (1M) Calculated over the trailing 1-month period	1.02%	14.54%	-13.52%
Volatility (6M) Calculated over the trailing 6-month period	5.47%	37.22%	-31.75%
Volatility (1Y) Calculated over the trailing 1-year period	7.32%	57.78%	-50.46%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	9.40%	76.85%	-67.45%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	9.50%	72.02%	-62.52%

Dividends

CVD.TO vs. RYTM - Dividend Comparison

CVD.TO's dividend yield for the trailing twelve months is around 4.94%, while RYTM has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CVD.TO iShares Convertible Bond Index ETF	4.94%	4.91%	5.14%	5.33%	5.05%	4.61%	4.48%	4.52%	4.97%	4.65%	4.51%	4.94%
RYTM Rhythm Pharmaceuticals, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both CVD.TO and RYTM in my portfolio?

CVD.TO and RYTM have a correlation of -0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.